Second-quarter results suggest the spinoff of the company's slow-growing consumer goods segment is having the intended effect. On July 17, Johnson & Johnson (JNJ 3.69%) announced second-quarter results that gave investors a lot to look forward to. Integration of newly acquired medical technology plus upcoming expansions of patentprotected medicines will help push the healthcare conglomerate's needle forward for years to come. Johnson & Johnson is made of many pieces that aren't moving in the same direction. ...